These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9178823

  • 21. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
    Inui A, Chung YS, Sawada T, Kondo Y, Ho JJ, Kim YS, Sowa M.
    Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462
    [Abstract] [Full Text] [Related]

  • 22. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R, Blumenthal R, Sharkey RM, Goldenberg DM.
    Cancer; 1994 Feb 01; 73(3 Suppl):816-23. PubMed ID: 8306265
    [Abstract] [Full Text] [Related]

  • 23. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J.
    Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194
    [Abstract] [Full Text] [Related]

  • 24. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
    Goel A, Augustine S, Baranowska-Kortylewicz J, Colcher D, Booth BJ, Pavlinkova G, Tempero M, Batra SK.
    Clin Cancer Res; 2001 Jan 01; 7(1):175-84. PubMed ID: 11205906
    [Abstract] [Full Text] [Related]

  • 25. Experimental radioimmunotherapy of a xenografted human glioma using 131I-labeled monoclonal antibody to epidermal growth factor receptor.
    Takahashi H, Nakazawa S, Herlyn D.
    Neurol Med Chir (Tokyo); 1993 Sep 01; 33(9):610-5. PubMed ID: 7505399
    [Abstract] [Full Text] [Related]

  • 26. Radioimmunotherapy of xenografts of human pancreatic carcinomas--intravenous and intratumoral application of 131I-labelled monoclonal antibodies.
    Klapdor R, Lander S, Bahlo M, Montz R.
    Nuklearmedizin; 1986 Dec 01; 25(6):235-8. PubMed ID: 3468486
    [Abstract] [Full Text] [Related]

  • 27. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J, Barendswaard E, Williams C, Yao TJ, Cohen AM, Old LJ, Welt S.
    Cancer Res; 1997 Jun 01; 57(11):2181-6. PubMed ID: 9187118
    [Abstract] [Full Text] [Related]

  • 28. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Stein R, Govindan SV, Hayes M, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM.
    Clin Cancer Res; 2005 Apr 01; 11(7):2727-34. PubMed ID: 15814655
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E, van Gog FB, Schlüper HM, van Dongen GA, Pinedo HM, Boven E.
    Int J Radiat Oncol Biol Phys; 1997 Jul 01; 38(4):813-23. PubMed ID: 9240651
    [Abstract] [Full Text] [Related]

  • 30. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G, Booth BJ, Batra SK, Colcher D.
    Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
    Andratschke M, Gildehaus FJ, Johannson V, Schmitt B, Mack B, Reisbach G, Lang S, Lindhofer H, Zeidler R, Wollenberg B, Luebbers CW.
    Anticancer Res; 2007 Sep 01; 27(1A):431-6. PubMed ID: 17352264
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer.
    Cardillo TM, Blumenthal R, Ying Z, Gold DV.
    Int J Cancer; 2002 Jan 20; 97(3):386-92. PubMed ID: 11774294
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 38. Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts.
    Kondo Y, Chung YS, Sawada T, Inui A, Yamashita Y, Hirayama K, Nakata B, Ho JJ, Kim YS, Sowa M.
    Jpn J Cancer Res; 1995 Nov 15; 86(11):1072-9. PubMed ID: 8567399
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA.
    J Nucl Med; 2006 Jul 15; 47(7):1127-35. PubMed ID: 16818947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.